Read More Pharma Industry News Cipla gets FDA’s final approval for generic version of Migranal with CGT designation Cipla has secured final approval for its abbreviated new drug application (ANDA) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL… bypharmanewsdailyMay 21, 2020
